Diagnostics
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,874
NCT03957252
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer
Phase: N/A
Role: Lead Sponsor
Start: Jun 6, 2019
Completion: Mar 31, 2027
NCT06678828
Clinical Utility of ClarityDX Prostate
Start: Apr 14, 2025
Completion: Dec 31, 2028
Loading map...